{"id":24412,"date":"2025-01-22T12:30:14","date_gmt":"2025-01-22T11:30:14","guid":{"rendered":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/"},"modified":"2025-01-22T12:30:14","modified_gmt":"2025-01-22T11:30:14","slug":"nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll","status":"publish","type":"post","link":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/","title":{"rendered":"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES"},"content":{"rendered":"<p>The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant and follow\u2010on formula of a specific protein hydrolysate from whey protein concentrate manufactured by Fonterra Co\u2010operative Group Ltd. Fonterra Co\u2010operative Group Ltd. submitted a dossier to the European Commission to request an amendment of Regulation (EU) 2016\/127 with respect to the protein sources that may be used in the manufacture of infant and\/or follow\u2010on formula. The protein hydrolysate under evaluation is sufficiently characterised with respect to the hydrolysed protein. In the pertinent intervention study provided, an infant formula manufactured from the protein hydrolysate with a protein content of 2.0 g\/100 kcal and consumed as the sole source of nutrition by infants for 3 months led to a growth similar to a formula manufactured from intact cow&#8217;s milk with the same protein content. Data on gastrointestinal tolerance of the formula did not raise any concerns. No experimental data have been provided on the nutritional safety and suitability of this protein source in follow\u2010on formula. Given that follow\u2010on formula is consumed with complementary foods and the protein source is nutritionally safe and suitable in an infant formula that is the sole source of nutrition of young infants, the Panel considers that the protein hydrolysate is also a nutritionally safe and suitable protein source for use in follow\u2010on formula. The Panel concludes that the protein hydrolysate under evaluation is a nutritionally safe and suitable protein source for use in infant and follow\u2010on formula, as long as the formula in which it is used contains a minimum of 2.0 g\/100 kcal protein and complies with the compositional criteria of Regulation (EU) 2016\/127 and the amino acid pattern in its Annex IIIA.<\/p>","protected":false},"excerpt":{"rendered":"<p>The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant and follow\u2010on formula of a specific protein hydrolysate from whey protein concentrate manufactured by Fonterra Co\u2010operative Group Ltd. Fonterra Co\u2010operative Group Ltd. submitted a dossier to the European Commission to request an amendment of Regulation (EU) [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[8,5,6],"tags":[],"class_list":["post-24412","post","type-post","status-publish","format-standard","hentry","category-ayudas-y-subvenciones","category-noticias","category-publicaciones"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.9 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES - bip4ex<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co\u2010operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES\" \/>\n<meta property=\"og:description\" content=\"The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant and follow\u2010on formula of a specific protein hydrolysate from whey protein concentrate manufactured by Fonterra Co\u2010operative Group Ltd. Fonterra Co\u2010operative Group Ltd. submitted a dossier to the European Commission to request an amendment of Regulation (EU) [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co\u2010operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/\" \/>\n<meta property=\"og:site_name\" content=\"bip4ex\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-22T11:30:14+00:00\" \/>\n<meta name=\"author\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luis Miguel Mej\u00edas Ramos\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/\"},\"author\":{\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\"},\"headline\":\"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\\\/NOTICIAS\\\/ADQUISCIONES\",\"datePublished\":\"2025-01-22T11:30:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/\"},\"wordCount\":330,\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"articleSection\":[\"Ayudas y Subvenciones\",\"Noticias\",\"Publicaciones\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/\",\"name\":\"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\\\/NOTICIAS\\\/ADQUISCIONES - bip4ex\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\"},\"datePublished\":\"2025-01-22T11:30:14+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\\\/NOTICIAS\\\/ADQUISCIONES\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#website\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"name\":\"bip4ex\",\"description\":\"Vigilancia Tecnol\u00f3gica\",\"publisher\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#organization\",\"name\":\"Helloproject.es\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"contentUrl\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/bip4ex.png\",\"width\":322,\"height\":365,\"caption\":\"Helloproject.es\"},\"image\":{\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/#\\\/schema\\\/person\\\/3767b0619d59a11570372c821f8619ca\",\"name\":\"Luis Miguel Mej\u00edas Ramos\",\"url\":\"https:\\\/\\\/helloproject.es\\\/vigilancia\\\/author\\\/luismi\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES - bip4ex","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co\u2010operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/","og_locale":"es_ES","og_type":"article","og_title":"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES","og_description":"The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability for use in infant and follow\u2010on formula of a specific protein hydrolysate from whey protein concentrate manufactured by Fonterra Co\u2010operative Group Ltd. Fonterra Co\u2010operative Group Ltd. submitted a dossier to the European Commission to request an amendment of Regulation (EU) [&hellip;]","og_url":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co\u2010operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/","og_site_name":"bip4ex","article_published_time":"2025-01-22T11:30:14+00:00","author":"Luis Miguel Mej\u00edas Ramos","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Luis Miguel Mej\u00edas Ramos","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/#article","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/"},"author":{"name":"Luis Miguel Mej\u00edas Ramos","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca"},"headline":"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES","datePublished":"2025-01-22T11:30:14+00:00","mainEntityOfPage":{"@id":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/"},"wordCount":330,"publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"articleSection":["Ayudas y Subvenciones","Noticias","Publicaciones"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/","url":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/","name":"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES - bip4ex","isPartOf":{"@id":"https:\/\/helloproject.es\/vigilancia\/#website"},"datePublished":"2025-01-22T11:30:14+00:00","breadcrumb":{"@id":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/helloproject.es\/vigilancia\/nutritional-safety-and-suitability-of-a-specific-protein-hydrolysate-manufactured-by-fonterra-co%e2%80%90operative-group-ltd-derived-from-a-whey-protein-concentrate-and-used-in-infant-formula-and-foll\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/helloproject.es\/vigilancia\/"},{"@type":"ListItem","position":2,"name":"Nutritional safety and suitability of a specific protein hydrolysate manufactured by Fonterra Co\u2010operative Group Ltd derived from a whey protein concentrate and used in infant formula and follow\u2010on formula AUTORIDAD EUROPEA DE SEGURIDAD ALIMENTARIA: SUBVENCIONES\/NOTICIAS\/ADQUISCIONES"}]},{"@type":"WebSite","@id":"https:\/\/helloproject.es\/vigilancia\/#website","url":"https:\/\/helloproject.es\/vigilancia\/","name":"bip4ex","description":"Vigilancia Tecnol\u00f3gica","publisher":{"@id":"https:\/\/helloproject.es\/vigilancia\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/helloproject.es\/vigilancia\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/helloproject.es\/vigilancia\/#organization","name":"Helloproject.es","url":"https:\/\/helloproject.es\/vigilancia\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/","url":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","contentUrl":"https:\/\/helloproject.es\/vigilancia\/wp-content\/uploads\/2023\/07\/bip4ex.png","width":322,"height":365,"caption":"Helloproject.es"},"image":{"@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/helloproject.es\/vigilancia\/#\/schema\/person\/3767b0619d59a11570372c821f8619ca","name":"Luis Miguel Mej\u00edas Ramos","url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/"}]}},"_links":{"self":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/24412","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/comments?post=24412"}],"version-history":[{"count":0,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/posts\/24412\/revisions"}],"wp:attachment":[{"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/media?parent=24412"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/categories?post=24412"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/helloproject.es\/vigilancia\/wp-json\/wp\/v2\/tags?post=24412"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}